Regulation
BlueWind Medical lands FDA clearance for UUI implant with 15-year lifespan
BlueWind Medical received FDA clearance for Revi Extend, an implantable neuromodulation device for urgency urinary incontinence (UUI) with a 15-year battery lifespan. The company plans to begin limited U.S. market launch in Q4 2026.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network